You bring the brief
The animal, what needs treating, and how the farmer or owner will give the medicine — in feed, in drinking water, by injection, or into the mouth.
Compounding means making a medicine to fit the job instead of taking whatever is already on the shelf. You tell us the animal, what needs treating and how the medicine has to be given. We choose the active from our own range, build the product around it, and manufacture it.
This page explains the idea in plain language, walks through what actually happens, and sets out clearly what Range Pharma can and cannot make.
Every compounded product starts from the same three questions. The answers decide the recipe.
Compounding is combining an active ingredient with the other materials it needs — carriers, solvents, flavours, stabilisers — so that it becomes a usable medicine for a particular animal, given in a particular way.
The active ingredient is the part that treats the animal, and we work from our own range of actives. On its own an active is usually a powder that will not dissolve properly, will not stay stable in the heat, and no animal would willingly swallow. Everything else in the product exists to fix that.
Both are real medicines made to the same standards. The difference is who the product was designed for.
A finished product already exists in one strength, one pack and one form. It suits you if your animal, your dose and your market happen to match what it was designed for. If they don't, there is nothing to adjust.
The active, the form, the strength, the flavour and the pack are chosen for that species, that indication and that market. A pig farm in a hot, humid climate and a cat in an apartment need different answers, even from the same active ingredient.
Brief, bench, proof, production. Every step happens inside our own plant and our own labs.
The animal, what needs treating, and how the farmer or owner will give the medicine — in feed, in drinking water, by injection, or into the mouth.
We select the active from our own range, then our formulators pick the carriers, solvents and flavours that make it dissolve, stay put and taste acceptable to that species. That recipe is the formulation.
Small trial batches go into stability testing under tropical heat and humidity, and into hard farm water, so we know the product still works at the end of its shelf life.
The approved recipe is scaled to production in our PIC/S GMP plant — any batch size you need — filled into the agreed pack format, tested by our own labs and released with full batch paperwork.
Said plainly, so nobody spends three emails finding out. If your project is on the right-hand list, we will tell you at the first conversation.
Veterinary products, formulated around what you need treated
Outside our licences, our facility or how we work
Range Pharma supplies distributors, importers and integrators — not individual pet owners or end users — and everything we compound is a Range Pharma product. Nothing on this site is veterinary advice: whether a medicine suits a particular animal is a decision for the vet treating it, and whether a product may be sold in a particular country depends on that country's registration rules.
Not quite. A generic copies an existing product's form and strength. Compounding starts from what you need — the active, the species, the route and the market — and builds the product to fit, which may be a form nobody sells yet.
No. Bring the species, the problem and how the medicine has to be given, and our R&D team selects the active from our own range and develops the formula. If you already have something specific in mind, tell us and we will say whether it is in our range.
No. Range Pharma does not do OEM or white-label manufacturing. What we compound is a Range Pharma formulation, made and supplied as a Range product — usually through a distributor in your market.
No. We run anything from trial quantities to full production, and every batch goes through the same GMP production, quality control and batch documentation.
We can provide the technical documentation a registration needs — specifications, method validation, stability data and batch records. The application itself is filed by the licence holder in that market.
It depends on how much development the product needs. A form we already run with a familiar active is fast; a new formulation that needs its own stability programme takes longer. We give an indicative timeline once we have the brief.
Send us the species, what you need treated and the market. We'll come back with an active, a dosage form recommendation and an indicative timeline.